Provided by Tiger Trade Technology Pte. Ltd.

Repligen

174.73
+6.734.01%
Post-market: 174.00-0.7300-0.42%19:56 EDT
Volume:891.26K
Turnover:155.20M
Market Cap:9.84B
PE:239.36
High:175.86
Open:168.27
Low:168.27
Close:168.00
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.04
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.66
PE(LYR):203.17

Loading ...

Earning Preview: Repligen Q1 revenue is expected to increase by 17%, and institutional views are bullish

Earnings Agent
·
Apr 28

Repligen CEO Olivier Loeillot sells $536,480 common shares

Reuters
·
Apr 23

Repligen sets conference call for quarterly results update

Reuters
·
Apr 22

Repligen to Report First Quarter 2026 Financial Results

GlobeNewswire
·
Apr 22

Repligen Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Apr 21

Repligen Initiated at Buy by Roth Capital

Dow Jones
·
Apr 17

Repligen Opens Third Global Training and Innovation Center

MT Newswires Live
·
Apr 17

Rothschild & Co Redburn Initiates Repligen at Buy With $160 Price Target

MT Newswires Live
·
Apr 17

Repligen opens new Training & Innovation Center in Netherlands

TIPRANKS
·
Apr 17

Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

GlobeNewswire
·
Apr 17

Q/C Technologies FY25 net loss narrows 50.4% to $11.6 million; no revenue

Reuters
·
Apr 16

Repligen Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

Repligen Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Apr 07

Repligen price target lowered to $140 from $170 at Evercore ISI

TIPRANKS
·
Apr 06

Reassessing Repligen (RGEN) Valuation After Recent Share Price Rebound And Bioprocessing Growth Expectations

Simply Wall St.
·
Apr 05

Repligen publishes 2025 annual report, posts $738 million revenue in 2025

Reuters
·
Apr 03

Repligen announces annual shareholder meeting notice and proxy statement

Reuters
·
Apr 03

Q/C Technologies delays annual report filing, seeks 15-day extension

Reuters
·
Apr 01

Is Repligen (RGEN) Pricing Look Attractive After Steep Multi Year Share Price Declines

Simply Wall St.
·
Apr 01

Repligen Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 23